Fatskills
Practice. Master. Repeat.
Study Guide: USMLE Pathology: Carcinogenesis, Chemical, Radiation, Viral Key Associations
Source: https://www.fatskills.com/usmle/chapter/usmle-pathology-carcinogenesis-chemical-radiation-viral-key-associations

USMLE Pathology: Carcinogenesis, Chemical, Radiation, Viral Key Associations

By Fatskills Exam Guides Team — the exam nerds behind 28,500+ quizzes and 2.1M practice questions across 500+ global exams.

⏱️ ~4 min read

What This Is and Why It Matters for USMLE

Carcinogenesis: Chemical, Radiation, Viral — Key Associations is a high-yield topic for Step 1 and Step 2 CK, with moderate relevance to Step 3. This topic is crucial for understanding the pathophysiology of cancer, its various causes, and the diagnostic and management approaches.

High-Yield Facts (What You Must Memorize)

  • Carcinogenesis is the process by which normal cells become malignant.
  • Chemical carcinogens (e.g., benzene, asbestos) cause DNA mutations leading to cancer.
  • Radiation carcinogenesis occurs through ionizing radiation (e.g., X-rays, gamma rays).
  • Viral carcinogenesis involves oncogenic viruses (e.g., HPV, EBV).
  • P53 tumor suppressor gene is a key target for many carcinogens.
  • Classic presentation and physical exam findings vary by cancer type (e.g., breast cancer: new lump, lung cancer: cough, skin cancer: new mole).
  • Diagnostic approach involves imaging (e.g., CT, MRI), biopsy, and laboratory tests (e.g., tumor markers).
  • First-line treatment and management depend on cancer type (e.g., surgery, chemotherapy, radiation therapy).
  • Red flags for cancer include weight loss, unintentional weight loss, and persistent symptoms.
  • Complications and follow-up depend on cancer type and treatment.

Clinical Pearls & Buzzwords

  • P53 mutation-Li-Fraumeni syndrome
  • HPV-cervical cancer
  • EBV-Burkitt lymphoma
  • Asbestos-mesothelioma

Step-by-Step Clinical Reasoning

  1. Identify the syndrome or presentation (e.g., new lump, persistent cough).
  2. Generate a differential (most likely and must-not-miss):
    • Cancer (e.g., breast, lung, skin)
    • Infection (e.g., pneumonia, abscess)
    • Other (e.g., pulmonary embolism, heart failure)
  3. Order appropriate initial tests (e.g., CT, MRI, biopsy).
  4. Interpret results and confirm the diagnosis.
  5. Initiate treatment and monitoring (e.g., surgery, chemotherapy, radiation therapy).

Common Mistakes & Exam Traps

  • The mistake: Missing a life-threatening complication (e.g., pulmonary embolism).
  • Why it happens: Rushing through the differential diagnosis.
  • How to avoid it: Take time to generate a comprehensive differential.
  • Exam board insight: The examiners penalize for missing critical complications.

  • The mistake: Failing to order a necessary test (e.g., biopsy).

  • Why it happens: Misreading the scenario or underestimating the importance of a test.
  • How to avoid it: Carefully read the scenario and prioritize necessary tests.
  • Exam board insight: The examiners expect you to order necessary tests to confirm the diagnosis.

  • The mistake: Delaying treatment due to uncertainty.

  • Why it happens: Overthinking or underestimating the severity of the condition.
  • How to avoid it: Trust your differential diagnosis and initiate treatment.
  • Exam board insight: The examiners penalize for delaying treatment.

How It’s Tested on USMLE

  • Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology).
  • Step 2 CK: Clinical vignette (e.g., "A 45-year-old with chest pain...").
  • Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.

CCS (Step 3) Relevance (If Applicable)

  • Initial orders: Order a CT or MRI to confirm the diagnosis.
  • Monitoring and follow-up: Monitor for complications (e.g., pulmonary embolism, infection) and tumor recurrence.
  • Common mistakes: Failing to order necessary tests (e.g., biopsy) or delaying treatment.

Practice Questions (3-5 single-best-answer)

Question: A 35-year-old woman presents with a new lump in her breast. Physical exam reveals a 2 cm mass. Labs are normal. What is the next best step in management?

Options: A) Order a CT to rule out metastasis. B) Perform a biopsy to confirm the diagnosis. C) Initiate chemotherapy due to high risk of recurrence. D) Refer to a surgeon for immediate surgery.

Answer: B) Perform a biopsy to confirm the diagnosis.

Explanation: A biopsy is necessary to confirm the diagnosis of breast cancer. A CT is not necessary at this stage, and chemotherapy is not indicated without a confirmed diagnosis. Referral to a surgeon is not the next best step without a confirmed diagnosis.

Question: A 60-year-old man presents with a persistent cough. Physical exam reveals a new lung mass. Labs are normal. What is the next best step in management?

Options: A) Order a CT to rule out metastasis. B) Perform a biopsy to confirm the diagnosis. C) Initiate chemotherapy due to high risk of recurrence. D) Refer to a pulmonologist for further evaluation.

Answer: B) Perform a biopsy to confirm the diagnosis.

Explanation: A biopsy is necessary to confirm the diagnosis of lung cancer. A CT is not necessary at this stage, and chemotherapy is not indicated without a confirmed diagnosis. Referral to a pulmonologist is not the next best step without a confirmed diagnosis.

Quick Reference Card (60-Second Summary)

  • P53 mutation-Li-Fraumeni syndrome
  • HPV-cervical cancer
  • EBV-Burkitt lymphoma
  • Asbestos-mesothelioma
  • First-line treatment: surgery, chemotherapy, radiation therapy
  • Must-remember lab values: tumor markers (e.g., CEA, CA-125)

If You Get Stuck on Test Day

  • Eliminate obviously wrong answers (e.g., CT for a confirmed diagnosis).
  • Use the "next best step" hierarchy (least invasive, most specific).
  • For Step 3 CCS, order basic labs (e.g., CBC, chem panel) and vitals to confirm the diagnosis.

Related USMLE Topics

  • Genetics: Connects to Li-Fraumeni syndrome and BRCA1/2 mutations.
  • Oncology: Connects to chemotherapy, radiation therapy, and targeted therapy.
  • Pathology: Connects to tumor markers, histopathology, and cytology.